Effect of TU-100 in Patients Undergoing Laparoscopic Colectomy
Public ClinicalTrials.gov record NCT02232893. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blinded, Placebo-Controlled Trial of TU-100 in Patients Undergoing Laparoscopic Colectomy
Study identification
- NCT ID
- NCT02232893
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Tsumura USA
- Industry
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Interventions
- Daikenchuto (TU-100) Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2014
- Primary completion
- Apr 30, 2017
- Completion
- Apr 30, 2017
- Last update posted
- Jun 18, 2020
2014 – 2017
United States locations
- U.S. sites
- 13
- U.S. states
- 12
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Los Angeles Site | Los Angeles | California | 90048 | — |
| Aurora Site | Aurora | Colorado | 80045 | — |
| Weston Site | Weston | Florida | 33331 | — |
| Atlanta Site | Atlanta | Georgia | 30342 | — |
| Chicago Site | Chicago | Illinois | 60637 | — |
| Metairie Site | Metairie | Louisiana | 70006 | — |
| Burlington, MA Site | Burlington | Massachusetts | 01805 | — |
| Coon Rapids Site | Coon Rapids | Minnesota | 55433 | — |
| Minneapolis Site | Minneapolis | Minnesota | 55407 | — |
| Jackson Site | Jackson | Mississippi | 39042 | — |
| Cleveland Site | Cleveland | Ohio | 44106 | — |
| Burlington, VT Site | Burlington | Vermont | 05401 | — |
| Spokane Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02232893, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 18, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02232893 live on ClinicalTrials.gov.